RITUXIMAB AND SARGRAMOSTIM IMMUNOTHERAPY FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANT FOR AGGRESSIVE NON-HODGKIN'S LYMPHOMA

被引：0

作者：

Scigliano, E. ^{[1
]}

Grosskreutz, C. L. ^{[1
]}

Osman, K. ^{[1
]}

Malone, A. ^{[1
]}

Nieto, J. ^{[1
]}

Isola, L. M. ^{[1
]}

机构：

[1] Mt Sinai Med Ctr, New York, NY 10029 USA

来源：

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2010年 / 16卷 / 02期

关键词：

D O I：

10.1016/j.bbmt.2009.12.167

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

136

引用

页码：S208 / S209

页数：3

共 50 条

[41] Immunotherapy with rituximab/interleukin-2 after autologous stem cell transplantation as treatment for CD20+ non-Hodgkin's lymphoma [J].

Holmberg, Leona A. ;

Maloney, David ;

Bensinger, William .

CLINICAL LYMPHOMA & MYELOMA, 2006, 7 (02) :135-139

[42] Clinical factors influencing engraftment in patients with non-Hodgkin lymphoma following autologous stem cell transplant. [J].

Skelton, William Paul ;

Lutfi, Forat ;

Wang, Yu ;

Rosenau, Emma ;

Murthy, Hemant S. ;

Brown, Randy ;

Wingard, John R. ;

Norkin, Maxim .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)

[43] Single or double autologous stem cell transplantation for transformed aggressive B-cell non-Hodgkin's lymphoma [J].

Clavert, A. ;

Roland, V. ;

Le Gouill, S. ;

Dubruille, V. ;

Mahe, B. ;

Gastinne, T. ;

Blin, N. ;

Chevallier, P. ;

Guillaume, T. ;

Delaunay, J. ;

Ayari, S. ;

Devys, A. ;

Flandrois, G. ;

Saulquin, B. ;

Moreau, A. ;

Moreau, P. ;

Harousseau, J. L. ;

Mohty, M. .

BONE MARROW TRANSPLANTATION, 2009, 43 :S211-S211

[44] The role of salvage therapy post autologous stem cell transplantation in aggressive non-Hodgkin's lymphoma. [J].

Yano, S ;

Sekiguchi, N ;

Asai, O ;

Dobashi, N ;

Sugiyama, K ;

Saito, T ;

Yahagi, Y ;

Osawa, H ;

Okawa, Y ;

Kasama, K ;

Hisatomi, M ;

Ueda, K ;

Hoshi, Y ;

Usui, N ;

Kobayashi, M .

BLOOD, 2003, 102 (11) :483B-483B

[45] High-dose therapy with autologous stem-cell transplantation in aggressive non-Hodgkin's lymphoma [J].

Verdonck, LF .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) :3003-3003

[46] Is Rituximab Needed With High Dose Chemotherapy and Autologous Stem Cell Transplant When Patients With Non-Hodgkin's Lymphoma Have Been Exposed To It? [J].

Gul, Zartash ;

Anderson, Stephan ;

Slone, Stacey ;

Chhabra, Saurabh ;

Monohan, Gregory ;

Howard, Dianna ;

Lawson, Amber ;

Hayslip, John .

BLOOD, 2013, 122 (21)

[47] High dose chemotherapy with autologous stem cell transplant for patients with transformed B-cell non-Hodgkin lymphoma in the rituximab era [J].

Blaker, Yngvild N. ;

Eide, Marianne B. ;

Liestol, Knut ;

Lauritzsen, Grete F. ;

Kolstad, Arne ;

Fossa, Alexander ;

Smeland, Erlend B. ;

Holte, Harald .

LEUKEMIA & LYMPHOMA, 2014, 55 (10) :2319-2327

[48] IMMUNOTHERAPY WITH RITUXIMAB (RITUXAN)/INTERLEUKIN 2 (IL-2) FOLLOWING AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANT (ASCT) AS TREATMENT FOR CD20 POSITIVE NON-HODGKIN'S LYMPHOMA [J].

Holmberg, L. A. ;

Maloney, D. G. ;

Bensinger, W., I .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) :39-39

[49] Evans' syndrome following autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma [J].

Kamezaki, K ;

Fukuda, T ;

Makino, S ;

Harada, M .

CLINICAL AND LABORATORY HAEMATOLOGY, 2004, 26 (04) :291-293

[50] Autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma [J].

Salles, G ;

Coiffier, B .

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 1999, 12 (1-2) :151-169

← 1 2 3 4 5 →